not recommended for use with DPP-4 inhibitors Common side effects : Gastrointestinal symptoms (nausea, vomiting, diarrhea) that typically diminish with continued use and proper dose titration Referral to endocrinology or obesity medicine specialists is appropriate for complex cases, including patients with multiple failed therapies, significant comorbidities, or those requiring comprehensive weight management programs
But when bombarded with toxins and free-radical damage from the sun, pollution, poor nutrition, or chronic stress, our bodies cant keep up
A deficiency in B12 can lead to nerve damage, causing symptoms like tingling or numbness in the hands and feet
ACA Marketplace plans commonly cover GLP-1 agonists approved for diabetes treatment, but rarely cover those approved for obesity Coverage in formularies varies widely among GLP-1 agonists
It also promotes a healthy mood and encourages healthy sleep patterns